Skip to main content
. 2017 Aug 23;12(8):e0183642. doi: 10.1371/journal.pone.0183642

Table 1. The clinical characteristics of study subjects stratified by CKD stages.


Entire Cohort
(n = 161)
CKD stage 1–3
(n = 65)
CKD stage 4–5
(n = 96)
P-value
    Demographic variables
    Age, year 67.2±7.8 67.7±7.8 66.8±7.8 0.48
    Sex (male), n% 87(54.0) 38(58.5) 49(51.0) 0.35
    Smoke (yes), n% 46(28.6) 19(29.2) 27(28.1) 0.87
    Alcohol (yes), n% 29(18.0) 12(18.5) 17(17.7) 0.90
    Marriage (yes), n% 132(82.0) 53(81.5) 79(82.3) 0.90
    Religion (yes), n% 135(90.0) 53(86.9) 82(92.1) 0.29
    Occupation (yes), n% 50(31.1) 17(26.2) 33(34.4) 0.26
    Education
     (senior high school or above) 83(51.6) 38(58.5) 45(46.9) 0.15
    Cardiovascular disease (yes), n% 24(15.0) 6(9.2) 18(18.9) 0.09
    Diabetes (yes), n% 60(37.3) 18(27.7) 42(43.8) 0.04
    Hypertension (yes), n% 114(70.8) 37(56.9) 77(80.2) 0.001
    Hyperlipidemia (yes), n% 66(41.0) 20(30.8) 46(47.9) 0.03
    Gout (yes), n% 28(17.4) 10(15.4) 18(18.8) 0.58
    Body Mass Index, kg/m2 24.4±3.8 24.4±4.0 24.3±3.8 0.82
    Physical activity
    2-minute step 105(92,115) 106(94,120) 104(90,112) 0.16
    Handgrip strength, kgf 26.9±7.7 28.0±7.5 26.1±7.8 0.12
    30-second chair stand 11.2±3.1 11.9±3.5 10.7±2.8 0.02
    Questionnaires of exercise capacity 0.005
    No exercise (yes), n% 8(5.0) 2(3.1) 6(6.3)
    Low activity (yes), n% 113(70.2) 45(69.2) 68(70.8)
    Middle+High activity (yes), n% 40(24.8) 21(32.3) 19(19.8)
Medications
    β-blocker (yes), n% 28(17.4) 9(13.8) 19(19.8) 0.32
    Calcium channel blocker (yes), n% 69(42.9) 15(23.1) 54(56.3) <0.001
    ACEI/ARB (yes), n% 52(32.3) 10(15.4) 42(43.8) <0.001
    Lipitor (yes), n% 33(20.5) 10(15.4) 23(24.0) 0.18
Quality of life
    Total score 52.3±5.3 53.2±5.2 51.4±5.2 0.03
    Physical domain 11.9±1.5 12.1±1.5 11.7±1.5 0.14
    Psychological domain 12.6±1.7 12.8±1.7 12.3±1.7 0.05
    Social domain 13.2±2.0 13.5±2.1 12.9±2.0 0.05
    Environment domain 14.7±1.5 14.8±1.5 14.6±1.4 0.25
Laboratory parameters
    Blood urea nitrogen, mg/dl 33.5(21.4,55.3) 19.7(14.7,23.8) 48.4(34.2,65.3) <0.001
    Creatinine, mg/dl 3.1±2.4 1.2±0.5 4.3±2.3 <0.001
    eGFR, ml/min/1.73m2 34.5±28.8 62.2±26.1 15.7±7.7 <0.001
    Hemoglobin, g/dl 11.0±2.0 12.5±1.8 10.5±1.8 <0.001
    Albumin, g/dl 4.2±0.3 4.3±0.4 4.2±0.4 0.18
    Phosphate, mg/dl 4.1(3.5,4.6) 3.6(3.2,3.9) 4.3(3.9,4.8) <0.001
    Calcium, meq/L 9.1±0.6 9.3±0.4 9.0±0.6 0.03
    Sodium, meq/L 139.0±2.6 139.7±2.0 138.6±2.8 0.01
    Potassium, meq/L 4.2±0.5 4.1±0.4 4.3±0.5 0.001
    Cholesterol, mg/dl 185.9±35.6 186.5±32.7 185.4±37.7 0.84
    Triglyceride, mg/dl 117.0(82.0,159.0) 115.1(81.0,144.5) 120.0(81.5,167.0) 0.23
    Urine protein-creatinine ratio, g/g 0.8(0.3,1.6) 0.2(0.1,0.5) 1.0(0.5,1.7) <0.001

Notes: Data are expressed as number (percentage) for categorical variables and mean±SD or median (25th, 75th percentile) for continuous variables, as appropriate.

Abbreviations: CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate